What Is MIFlowCyt And The FlowRepository, Or Why Flow Cytometry Is Being Standardized

Flow cytometry is a powerful screening tool that can be used to help identify target candidates on phenotypically defined cell populations.

There are a myriad of possible assays that can be combined using flow cytometry to examine the effects on these cells. Not to mention the fact that millions of cells can be measured in one experiment, or the statistical power of flow cytometry.

Of course, for these assays to be robust and reproducible within an individual lab, adherence to standard operating procedures and current best practices in flow cytometry is required. New dyes, new protocols, and new reagents are being released on a regular basis and must be titrated, optimized, and validated to ensure high quality data is generated.

Methods sections in scientific papers are often unable to capture all the critical data necessary to accurately reproduce the results in another lab. This continues to exacerbate the concerns Begley and Ellis (and others) raise about reproducibility. Thus, there is growing need to develop methods for communicating more details about the design and execution of an experiment.

In fact, over the last several years, these concerns have surfaced as a critical discussion about the standardization and reproducibility of scientific data. Data that can not be reproduced wastes time, energy and resources.

Why Flow Cytometry Needs Standardization

In their commentary in Nature, Begley and Ellis discuss their experiences in attempting to reproduce ‘landmark’ findings and how only a very low percentage of these were able to be reproduced.

With the pressures to discover new drugs and treatments, this is a huge waste of effort by all concerned, including both academia and industry, and is one of the drivers of the increasing costs of drug discovery. These cost increases led to the National Institutes of Health developing policies to improve rigor and reproducibility in scientific research.

Collins and Tabak discussed this Nature commentary, as did the editor-in-chief of the journal, Science. Soon, as discussed here, new applications to the NIH will be required to address issues of rigor and reproducibility.

The NIH has focused on four areas of reproducibility:

  1. The scientific premise of the proposed research
  2. Rigorous experimental design for robust and unbiased results
  3. Consideration of relevant biological variables
  4. Authentication of key biological and/or chemical resources

As described below, Dr. Ryan Brinkman provides information on two specific ways in which flow cytometry researchers are effectively communicating the above information to the flow cytometry community to improve reproducibility and consistency.

These two ways include first, the use of the MIFlowCyt standard and second, sharing data using the Flow Repository. This information was recently covered in exceptional detail in a special online lecture that Dr. Ryan Brinkman, a distinguished scientist in the Terry Fox Laboratory at the British Columbia Cancer Agency, and professor of Medical Genetics at the University of British Columbia, delivered to the ExCyte Mastery Class. Enter Dr. Brinkman…

The MIFlowCyt Standard And The FlowRepository

Flow cytometry (FCM) datasets that are currently being generated will be two orders of magnitude larger than any that exist today.

New flow cytometry instruments are available that increase the number of parameters measured for each single cell by to 30. The complexity of such datasets creates challenges in both annotation and data sharing. How do we solve this?

The rapidly expanding availability of FCM datasets through public repositories lays the foundation for researchers to integrate data from multiple research areas and diseases. This is leading to a culture where a large body of annotated and shareable data is available online to the broad biomedical research community. As a result, the development and use of data and metadata (‘data about the data’) standards are critical for achieving this goal.

An important step in curating large FCM datasets is knowing what information needs to be captured. Minimum information guidelines for reporting experiments has found broad-based support (see MIBBI) across biological and technological domains. For flow cytometry data, The Minimum Information about a Flow Cytometry Experiment (MIFlowCyt) effort is now an approved International Society for the Advancement of Cytometry (ISAC) standard and has been adopted by journals, including Cytometry A.

MIFlowCyt provides a checklist covering details including experimental overview, sample description, instrumentation, reagents, and data analysis. Almost all articles now published in Cytometry A follow this recommendation.

The FlowRepository | Expert Cytometry | flow cytometry standardization

Data sharing is also widely recognized as critical by funders and journals including Nature, PLOS and NIH. The FlowRepository is primarily for sharing data associated with peer-reviewed publications annotated according to MIFlowCyt data annotation requirements.

The FlowRepository operates under the auspices of ISAC with guidance provided by ICCS and ESCCA. Together MIFlowCyt and FlowRepository provide a mechanism for researchers to access, review, download, deposit, annotate, share and analyze flow cytometry datasets. This article shares more on how to create a MIFlowCyt compliant manuscript using the FlowRepository.

Since methodology sections in peer-reviewed journal papers often fail to capture all the critical data necessary to accurately reproduce flow cytometry results, efforts have been taken to help flow cytometry researchers improve reproducibility and consistency. Two such efforts are the development and use of the use of the MIFlowCyt standard and second, sharing data using the FlowRepository.

To learn more about publishing your flow cytometry data, and to get access to all of our advanced materials including 20 training videos, presentations, workbooks, and private group membership, get on the Flow Cytometry Mastery Class wait list.

Join Expert Cytometry's Mastery Class
Tim Bushnell, PhD
Tim Bushnell, PhD

Tim Bushnell holds a PhD in Biology from the Rensselaer Polytechnic Institute. He is a co-founder of—and didactic mind behind—ExCyte, the world’s leading flow cytometry training company, which organization boasts a veritable library of in-the-lab resources on sequencing, microscopy, and related topics in the life sciences.

Similar Articles

Understanding Clinical Trials And Drug Development As A Research Scientist

Understanding Clinical Trials And Drug Development As A Research Scientist

By: Deepak Kumar, PhD

Clinical trials are studies designed to test the novel methods of diagnosing and treating health conditions – by observing the outcomes of human subjects under experimental conditions.  These are interventional studies that are performed under stringent clinical laboratory settings. Contrariwise, non-interventional studies are performed outside the clinical trial settings that provide researchers an opportunity to monitor the effect of drugs in real-life situations. Non-interventional trials are also termed observational studies as they include post-marketing surveillance studies (PMS) and post-authorization safety studies (PASS). Clinical trials are preferred for testing newly developed drugs since interventional studies are conducted in a highly monitored…

How To Profile DNA And RNA Expression Using Next Generation Sequencing (Part-2)

How To Profile DNA And RNA Expression Using Next Generation Sequencing (Part-2)

By: Deepak Kumar, PhD

In the first blog of this series, we explored the power of sequencing the genome at various levels. We also dealt with how the characterization of the RNA expression levels helps us to understand the changes at the genome level. These changes impact the downstream expression of the target genes. In this blog, we will explore how NGS sequencing can help us comprehend DNA modification that affect the expression pattern of the given genes (epigenetic profiling) as well as characterizing the DNA-protein interactions that allow for the identification of genes that may be regulated by a given protein.  DNA Methylation Profiling…

How To Profile DNA And RNA Expression Using Next Generation Sequencing

How To Profile DNA And RNA Expression Using Next Generation Sequencing

By: Deepak Kumar, PhD

Why is Next Generation Sequencing so powerful to explore and answer both clinical and research questions. With the ability to sequence whole genomes, identifying novel changes between individuals, to exploring what RNA sequences are being expressed, or to examine DNA modifications and protein-DNA interactions occurring that can help researchers better understand the complex regulation of transcription. This, in turn, allows them to characterize changes during different disease states, which can suggest a way to treat said disease.  Over the next two blogs, I will highlight these different methods along with illustrating how these can help clinical diagnostics as well as…

What Is Next Generation Sequencing (NGS) And How Is It Used In Drug Development

What Is Next Generation Sequencing (NGS) And How Is It Used In Drug Development

By: Deepak Kumar, PhD

NGS methodologies have been used to produce high-throughput sequence data. These data with appropriate computational analyses facilitate variant identification and prove to be extremely valuable in pharmaceutical industries and clinical practice for developing drug molecules inhibiting disease progression. Thus, by providing a comprehensive profile of an individual’s variome — particularly that of clinical relevance consisting of pathogenic variants — NGS helps in determining new disease genes. The information thus obtained on genetic variations and the target disease genes can be used by the Pharma companies to develop drugs impeding these variants and their disease-causing effect. However simple this may allude…

7 Key Image Analysis Terms For New Microscopist

7 Key Image Analysis Terms For New Microscopist

By: Heather Brown-Harding, PhD

As scientists, we need to perform image analysis after we’ve acquired images in the microscope, otherwise, we have just a pretty picture and not data. The vocabulary for image processing and analysis can be a little intimidating to those new to the field. Therefore, in this blog, I’m going to break down 7 terms that are key when post-processing of images. 1. RGB Image Images acquired during microscopy can be grouped into two main categories. Either monochrome (that can be multichannel) or “RGB.” RGB stands for red, green, blue – the primary colors of light. The cameras in our phones…

We Tested 5 Major Flow Cytometry SPADE Programs for Speed - Here Are The Results

We Tested 5 Major Flow Cytometry SPADE Programs for Speed - Here Are The Results

By: Tim Bushnell, PhD

In the flow cytometry community, SPADE (Spanning-tree Progression Analysis of Density-normalized Events) is a favored algorithm for dealing with highly multidimensional or otherwise complex datasets. Like tSNE, SPADE extracts information across events in your data unsupervised and presents the result in a unique visual format. Given the growing popularity of this kind of algorithm for dealing with complex datasets, we decided to test the SPADE algorithm in 5 software packages, including Cytobank, FCS Express, FlowJo, R, and the original, free software made available by the author of SPADE. Which was the fastest?

5 FlowJo Hacks To Boost The Quality Of Your Flow Cytometry Analysis

5 FlowJo Hacks To Boost The Quality Of Your Flow Cytometry Analysis

By: Tim Bushnell, PhD

FlowJo is a powerful tool for performing and analyzing flow cytometry experiments, if you know how to use it to the fullest. This includes understanding embedding and using keywords, the FlowJo compensation wizard, spillover spreading matrix, FlowJo and R, and creating tables in FlowJo. Extending your use of FJ using these hacks will help organize your data, improve analysis and make your exported data easier to understand and explain to others. Take a few moments and explore all you can do with FJ beyond just gating populations.

Statistical Challenges Of Rare Event Measurements In Flow Cytometry

Statistical Challenges Of Rare Event Measurements In Flow Cytometry

By: Tim Bushnell, PhD

It is necessary to sort through hundreds of thousands or millions of cells to find the few events of interest. With such low event numbers, we move away from the comfortable domain of the Gaussian distribution and move into the realm of Poisson statistics. There are 3 points to consider to build confidence in the data that the events being counted are truly events of interest and not random events that just happen to fall into the gates of interest.

How to Optimize Flow Cytometry Hardware For Rare Event Analysis

How to Optimize Flow Cytometry Hardware For Rare Event Analysis

By: Tim Bushnell, PhD

Preparing for rare event analysis requires an understanding of the power and limitation of the instrument to be used. From how fast to run the fluidics, to how the signal is processed to the number of gates that can be used in the sorting experiment, each factor impacts the outcome of the experiment.

Top Technical Training eBooks

Get the Advanced Microscopy eBook

Get the Advanced Microscopy eBook

Heather Brown-Harding, PhD

Learn the best practices and advanced techniques across the diverse fields of microscopy, including instrumentation, experimental setup, image analysis, figure preparation, and more.

Get The Free Modern Flow Cytometry eBook

Get The Free Modern Flow Cytometry eBook

Tim Bushnell, PhD

Learn the best practices of flow cytometry experimentation, data analysis, figure preparation, antibody panel design, instrumentation and more.

Get The Free 4-10 Compensation eBook

Get The Free 4-10 Compensation eBook

Tim Bushnell, PhD

Advanced 4-10 Color Compensation, Learn strategies for designing advanced antibody compensation panels and how to use your compensation matrix to analyze your experimental data.